A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors (Q81638797)
Jump to navigation
Jump to search
scientific article published on 11 April 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors |
scientific article published on 11 April 2005 |
Statements
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors (English)
A A Desai
R L Schilsky
A Young
L Janisch
W M Stadler
N J Vogelzang
S Cadden
11 April 2005